
KILROY REALTY CORP
100
Recent developments include the Q1 2026 earnings release and transcript, reporting a net loss and impairment charges, share repurchase activity, and new board appointments.
- Kilroy Realty reported Q1 2026 revenues of approximately $270 million and a net loss of $19.3 million, or $(0.16) per share, including impairment charges of $61.8 million and gains on property sales of $23.5 million [N1][N2][N3][N4][S2].
- The company repurchased approximately 2.36 million shares during Q1 2026 under its share repurchase program [S2].
- Kilroy Realty announced new appointments to its board of directors in February 2026 [N8].
- The company’s Q1 2026 earnings call and transcripts provide detailed discussion of operational metrics and financial results [N1][N7].
Kilroy Realty Corporation is a self-administered real estate investment trust (REIT) that owns, manages, develops, and acquires premier office, life science, and mixed-use properties in key U.S. markets including the San Francisco Bay Area, Los Angeles, Seattle, San Diego, and Austin. The company operates primarily through its wholly owned subsidiary, Kilroy Realty, L.P., which holds substantially all of the company’s assets and conducts its operations. The stabilized portfolio as of March 31, 2026, includes 123 office and life science buildings totaling approximately 17.1 million rentable square feet with 437 tenants and an economic occupancy rate of 77.6%. The company also owns stabilized residential properties and maintains a pipeline of nine potential future development sites. Kilroy Realty’s business model involves acquiring, developing, and managing properties to serve technology, media, life science, and professional services tenants. The company’s operations include ownership interests in consolidated property partnerships and joint ventures. Capital management activities include a share repurchase program and maintenance of a revolving credit facility. The company faces risks typical of real estate investment trusts, including illiquidity of real estate assets, competition for acquisitions, development and redevelopment risks, ground lease restrictions, and exposure to property tax reassessments. The company’s portfolio concentration in West Coast and select U.S. markets exposes it to regional economic and real estate market conditions [S1][S2].
Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. Kilroy Realty Corporation is a publicly traded REIT focused on premier office, life science, and mixed-use properties primarily in West Coast and select U.S. markets. The company operates through its wholly owned subsidiary Kilroy Realty, L.P., owning a diversified portfolio of stabilized properties and development sites. As of March 31, 2026, the company reported revenues of approximately $270 million for Q1 2026 and a net loss of $19.3 million, reflecting impairment charges and gains on property sales. The company maintains significant liquidity with $192.9 million in cash and an undrawn $1.1 billion revolving credit facility. Risks include real estate illiquidity, development execution, ground lease restrictions, and regional market exposure. Recent news includes Q1 2026 earnings disclosures and board appointments [S2][N1][N8].
Kilroy Realty’s business benefits from its focus on high-quality office and life science properties in key U.S. innovation hubs with strong demand from technology and life science tenants. The company’s diversified portfolio and development pipeline provide opportunities to enhance asset value and generate income. Its leadership in sustainability and operational excellence supports tenant satisfaction and occupancy. The company’s liquidity position, including cash reserves and an undrawn revolving credit facility, provides financial flexibility. Share repurchase activity indicates capital return initiatives. The company’s ability to manage development and redevelopment projects and capitalize on market opportunities in its target regions supports its operational resilience [S2][N1][N4].
Kilroy Realty faces risks related to the illiquid nature of real estate assets, which may limit its ability to sell properties quickly or on favorable terms. Development and redevelopment projects carry execution risks including cost overruns, delays, and leasing challenges. Ground lease and restrictive agreements limit property use and may impact value and leasing flexibility. The company’s portfolio concentration in West Coast and select U.S. markets exposes it to regional economic downturns and real estate market volatility. Property tax reassessments and rate changes could increase operating costs. Competition from other institutional investors may increase acquisition costs and limit opportunities. Impairment charges and net losses reported in recent periods highlight operational and market challenges [S1][S2][N3].
Kilroy Realty’s moat is supported by its focus on premier office and life science properties in high-barrier-to-entry U.S. markets such as the San Francisco Bay Area, Los Angeles, Seattle, San Diego, and Austin. The company’s portfolio concentration in these strategic markets, combined with its expertise in developing and managing modern business environments tailored to technology, media, life science, and professional services tenants, creates competitive advantages. Additionally, Kilroy Realty’s leadership in sustainability and building operations enhances tenant appeal and retention. The company’s ownership structure through its Operating Partnership and consolidated property partnerships provides operational control and flexibility. However, the illiquid nature of real estate assets and competition from other institutional investors remain ongoing challenges. The company’s ability to execute development and redevelopment projects successfully and manage ground lease restrictions also contributes to its competitive positioning [S1][S2].
• Real Estate Illiquidity and Market Risks: Properties are illiquid assets, limiting the company’s ability to sell quickly or on favorable terms. Market conditions and competition may adversely affect acquisitions and dispositions [S1].
• Development and Redevelopment Execution Risks: The company faces risks of delays, cost overruns, leasing challenges, and potential write-offs in development and redevelopment projects [S1].
• Ground Lease and Restrictive Agreements: Certain properties are subject to ground leases and restrictive agreements that limit use, leasing, and sale, potentially impacting value and operational flexibility [S1].
• Regional Market Concentration: Concentration in West Coast and select U.S. markets exposes the company to regional economic and real estate market fluctuations [S1].
• Property Tax Reassessment Risks: Property tax reassessments or rate changes could increase operating expenses and adversely affect financial results [S1].
• Competition for Acquisitions: Competition from other institutional investors may increase acquisition prices and limit opportunities [S1].
Business trends: Concentration on premier office, life science, and mixed-use properties in strategic U.S. markets with active development and redevelopment pipeline.
Execution milestones: Recent Q1 2026 financial results including impairment recognition, share repurchase activity, and board appointments.
Key risks: Illiquidity of real estate assets, development execution challenges, ground lease restrictions, regional market exposure, and property tax reassessment risks.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- Kilroy Realty Corporation is a publicly traded real estate investment trust (REIT) listed on the NYSE under ticker KRC [S1].
- The company operates primarily through its wholly owned subsidiary Kilroy Realty, L.P. (Operating Partnership), which owns substantially all assets and conducts operations [S1].
- Kilroy Realty focuses on premier office, life science, and mixed-use properties in key U.S. markets including San Francisco Bay Area, Los Angeles, Seattle, San Diego, and Austin [S1].
- As of March 31, 2026, the stabilized portfolio included 123 office and life science buildings totaling approximately 17.1 million rentable square feet with 437 tenants and 77.6% economic occupancy [S2].
- The company also owns stabilized residential properties and has a future development pipeline consisting of nine potential development sites [S2].
- Kilroy Realty’s business model includes owning, managing, developing, and acquiring office and life science properties, with some mixed-use developments that may include residential and retail components [S1].
- The company owns interests in properties through consolidated property partnerships and joint ventures, with ownership percentages typically around 56% for key partnerships [S2].
- Kilroy Realty’s financial results for Q1 2026 included total revenues of approximately $270 million and a net loss available to common stockholders of $19.3 million, or $(0.16) per share [S2].
- The company reported impairment charges on real estate assets of $61.8 million in Q1 2026 and gains on sales of depreciable operating properties of $23.5 million [S2].
- Cash and cash equivalents were $192.9 million as of March 31, 2026 [S2].
- Kilroy Realty repurchased approximately 2.36 million shares during Q1 2026 under its share repurchase program [S2].
- The company’s unsecured revolving credit facility has a borrowing capacity of $1.1 billion with no outstanding borrowings as of March 31, 2026 [S2].
- Kilroy Realty faces risks typical of real estate investment trusts including illiquidity of real estate assets, competition for acquisitions, risks in development and redevelopment projects, ground lease restrictions, and exposure to property tax reassessments [S1].
- The company’s portfolio concentration in West Coast and select U.S. markets exposes it to regional economic and real estate market conditions [S1].
- Kilroy Realty’s recent news includes Q1 2026 earnings transcripts and analysis highlighting the net loss, FFO performance, and operational metrics [N1][N2][N3][N4].
- The company announced new board appointments in February 2026 [N8].
- Kilroy Realty’s share-based compensation programs and capital management activities are disclosed, including RSU grants and repurchases [S2].
Generated 2026-04-29
- S1 | 2026-02-10 | 10-K
- S2 | 2026-04-28 | 10-Q
- N1 | 2026-04-28 | www.nasdaq.com | Kilroy Realty (KRC) Q1 2026 Earnings Transcript | https://www.nasdaq.com/articles/kilroy-realty-krc-q1-2026-earnings-transcript
- N2 | 2026-04-27 | www.nasdaq.com | Compared to Estimates, Kilroy Realty (KRC) Q1 Earnings: A Look at Key Metrics | https://www.nasdaq.com/articles/compared-estimates-kilroy-realty-krc-q1-earnings-look-key-metrics
- N3 | 2026-04-27 | www.nasdaq.com | Kilroy Realty Posts Q1 Loss | https://www.nasdaq.com/articles/kilroy-realty-posts-q1-loss
- N4 | 2026-04-27 | www.nasdaq.com | Kilroy Realty (KRC) Surpasses Q1 FFO Estimates | https://www.nasdaq.com/articles/kilroy-realty-krc-surpasses-q1-ffo-estimates
- N5 | 2026-04-22 | www.nasdaq.com | Kilroy Realty (KRC) Q4 2024 Earnings Transcript | https://www.nasdaq.com/articles/kilroy-realty-krc-q4-2024-earnings-transcript
- N6 | 2026-04-22 | www.nasdaq.com | Unveiling Kilroy Realty (KRC) Q1 Outlook: Wall Street Estimates for Key Metrics | https://www.nasdaq.com/articles/unveiling-kilroy-realty-krc-q1-outlook-wall-street-estimates-key-metrics
- N7 | 2026-04-21 | www.nasdaq.com | Kilroy (KRC) Q4 2025 Earnings Call Transcript | https://www.nasdaq.com/articles/kilroy-krc-q4-2025-earnings-call-transcript
- N8 | 2026-02-26 | www.nasdaq.com | Kilroy Realty Announces New Appointments To Board | https://www.nasdaq.com/articles/kilroy-realty-announces-new-appointments-board
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


